Product logins

Find logins to all Clarivate products below.


Blog: Market Access

Here you will find relevant articles and insight into all Clarivate related products and news.

The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
Biopharma Commercialization FDA
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Biopharma HMO IDN
Understanding the epidemiology of SMA Understanding the epidemiology of SMA
Blog December 18, 2025
Understanding the epidemiology of SMA
Business Development Epidemiology Market Access
GLP-1 weight loss access comes down to a dogfight in the U.S. GLP-1 weight loss access comes down to a dogfight in the U.S.
Blog October 3, 2025
GLP-1 weight loss access comes down to a dogfight in the U.S.
DRG Fingertip GLP-1 Market Access
How creative design can elevate your healthcare value communication tools How creative design can elevate your healthcare value communication tools
Blog September 12, 2025
How creative design can elevate your healthcare value communication tools
Biopharma Diagnostics Market Access
5 key time-saving benefits of AI-driven regulatory intelligence 5 key time-saving benefits of AI-driven regulatory intelligence
Blog September 10, 2025
5 key time-saving benefits of AI-driven regulatory intelligence
AI Biopharma Biotech
Streamlining regulatory compliance with AI-enabled intelligence Streamlining regulatory compliance with AI-enabled intelligence
Blog September 2, 2025
Streamlining regulatory compliance with AI-enabled intelligence
AI Biopharma Commercialization

Market Access

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Understanding the epidemiology of SMA Understanding the epidemiology of SMA
Blog December 18, 2025
Understanding the epidemiology of SMA
GLP-1 weight loss access comes down to a dogfight in the U.S. GLP-1 weight loss access comes down to a dogfight in the U.S.
Blog October 3, 2025
GLP-1 weight loss access comes down to a dogfight in the U.S.
How creative design can elevate your healthcare value communication tools How creative design can elevate your healthcare value communication tools
Blog September 12, 2025
How creative design can elevate your healthcare value communication tools
5 key time-saving benefits of AI-driven regulatory intelligence 5 key time-saving benefits of AI-driven regulatory intelligence
Blog September 10, 2025
5 key time-saving benefits of AI-driven regulatory intelligence
Streamlining regulatory compliance with AI-enabled intelligence Streamlining regulatory compliance with AI-enabled intelligence
Blog September 2, 2025
Streamlining regulatory compliance with AI-enabled intelligence
These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington